Press release
Maxis Clinical Sciences Announces Expansion to the UK and Europe, Strengthening Global Clinical Research and Development
Maxis Clinical Sciences: Transforming Global Clinical R&D with UK & Europe Expansion #ClinicalInnovation #MaxisClinicalSciences
Since its inception, Maxis Clinical Sciences has been committed to providing customized solutions to clients by bridging the gap between clinical sciences and digital advancements. Offering a comprehensive range of services covering every aspect of clinical research operations, Maxis Clinical Sciences has consistently been at the forefront of innovation in the life sciences and healthcare industries.
With over two decades of experience, Maxis has established a strong reputation for providing clients with the highest levels of quality, efficiency, and regulatory compliance. Expanding into the UK and Europe will enable Maxis to utilize its expertise in a new market and continue its commitment to excellence.
The UK and Europe lead in clinical research and development, boasting robust infrastructure and a highly skilled workforce. This expansion will permit Maxis Clinical to leverage available resources and offer its services to a wider range of clients, including biotech, pharmaceutical, biopharmaceutical, and CRO companies. The new location will also facilitate Maxis Clinical's expansion of its clinical trial capabilities, providing access to a more diverse patient population and enhancing its ability to meet the needs of global clients.
"Expanding our presence in the UK and Europe is a strategic move for Maxis, and we are eager to bring our clinical consulting expertise and solutions to this market," said Divya Reddy, President at Maxis Clinical Sciences. We believe that our expansion will offer significant value to our clients, and we are committed to delivering the same high levels of quality, efficiency, and regulatory compliance that we are known for."
For more information on Maxis Clinical Sciences and its services, visit www.maxisclinical.com and follow on LinkedIn, Twitter, Facebook, and Instagram.
Company Information:
Maxis Clinical Sciences
510 Thornall Street, Suite 180 Edison,
NJ 08837, USA
www.maxisclinical.com
Contact Informations:
Divya Reddy, President
+1-732-889-2444
DReddy@maxisclinical.com
Arati Kapileshwari
Head, Business Operations-Clinical Services
+1 732-331-6820
Arati.K@maxisclinical.com
Amanda Borgerhoff
Managing Partner - UK & Europe
+44 7444614561
Amanda.B@maxisclinical.com
Press/Media Contact:
Sneha Gupta
Senior Manager, Product Marketing
+91 9619780187
Sneha.Gupta@maxisclinical.com
About Maxis Clinical Sciences:
Maxis Clinical Sciences is a trusted brand for small to medium-sized pharmaceuticals and life sciences companies worldwide, offering guidance on strategic transformation initiatives involving digital trials, patient-centric solutions, and clinical functional and digital services. The company is expanding internationally, creating a niche in providing management consulting and functional services within clinical R&D to commercial business functions for global audiences, and bridging the gap between clinical sciences and digital innovation.
The Maxis Clinical Sciences brand represents an international voice that guarantees optimal results, regardless of geographical location. The company offers a range of services that include:
o Business Model Transformation
o Technology Advisory Services | Digital Strategies
o Talent Mapping & Leadership Advisory Services
o Commercial & Market Mapping Strategies
o Functional Outsourcing Strategies and Services
Maxis Clinical Sciences values transparency, ensuring their policies, terms, and conditions are as clear as possible. The company's outcome-centric model emphasizes trust, transparency, ownership, and end-to-end transformation, with the aim of maintaining value mapping and delivery in every client engagement.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Maxis Clinical Sciences Announces Expansion to the UK and Europe, Strengthening Global Clinical Research and Development here
News-ID: 3024518 • Views: …
More Releases from Maxis Clinical Sciences
Maxis Clinical Sciences Publishes Whitepaper on GenAI Adoption for Pharma Leader …
Maxis Clinical Sciences (MCS), a trusted consulting firm specializing in clinical research and strategic advisory services for the pharmaceutical and life sciences industries, has today released a whitepaper titled "Guidance on GenAI Adoption for Pharma Leaders."
This whitepaper provides an in-depth analysis of GenAI applications, benefits, challenges, and strategic implementation steps. It offers pharma executives practical guidance on implementing Generative Artificial Intelligence (GenAI) in the pharmaceutical sector.
Key insights from the whitepaper…
Maxis Clinical Sciences Publishes A Whitepaper On Opportunities of using Generat …
Maxis Clinical Sciences (MCS), a trusted brand and management consulting and strategic advisory company for Pharma and Life Sciences companies, has today published a comprehensive whitepaper that discusses the remarkable possibilities of generative artificial intelligence (Generative AI) in various industries.
Titled "Opportunities of using Generative Artificial Intelligence (Generative AI)," the whitepaper provides an in-depth analysis of how this unique technology is helping healthcare, education, and decision-making processes. This expert analysis aims…
Maxis Clinical Sciences Publishes Whitepaper on Generating Synthetic Medical Dat …
New Jersey, June 24, 2024 -- Maxis Clinical Sciences (MCS), a trusted brand and management consulting and strategic advisory company for Pharma and Life Sciences Innovators, today published a groundbreaking whitepaper focusing on synthetic medical data generation.
Titled "Generating Synthetic Medical Data: A Comprehensive Approach," the whitepaper provides an in-depth examination of the methodologies, applications, and future directions in synthetic medical data generation. This expert analysis aims to contribute to the…
Maxis Clinical Sciences Launches New Website to Drive Global Engagement and Fost …
Edison, New Jersey, [28 February, 2024] -- Maxis Clinical Sciences (MCS), a trusted brand and expert management consulting and strategic advisory organization for Pharma and Life Sciences Innovators, is delighted to announce the launch of its newly redesigned website. This initiative reflects MCS's dedication to global growth and delivering innovative solutions for the industry's evolving demands.
The newly revamped website represents a significant leap forward for MCS, strategically extending its global…
More Releases for Europe
2019 Strategy Consulting Market Analysis | McKinsey, The Boston Consulting Group …
Strategy Consulting Market reports also offer important insights which help the industry experts, product managers, CEOs, and business executives to draft their policies on various parameters including expansion, acquisition, and new product launch as well as analyzing and understanding the market trends
Need for strategic planning in highly competitive environment and to develop business capabilities to meet & exceed the emerging requirements are the major drivers which help in surging…
Strategy Consulting Market 2025 | Analysis By Top Key Players: Booz & Co. , Rola …
Global Strategy Consulting Market 2019-2025, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
The key players covered in this study
McKinsey , The Boston Consulting Group , Bain & Company , Booz & Co. , Roland Berger Europe…
Digital Strategy Consulting Market is Thriving Worldwide with Deloitte, McKinsey …
A Digital Strategy is a form of strategic management and a business answer or response to a digital question, often best addressed as part of an overall business strategy. A digital strategy is often characterized by the application of new technologies to existing business activity and focus on the enablement of new digital capabilities to their business.
A new report as a Digital Strategy Consulting market that includes a comprehensive analysis…
Strategy Consulting Market 2019: By McKinsey, The Boston Consulting Group, Bain …
This report studies the global Strategy Consulting market, analyzes and researches the Strategy Consulting development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
• McKinsey
• The Boston Consulting Group
• Bain & Company
• Booz & Co.
• Roland Berger Europe
• Oliver Wyman Europe
• A.T. Kearney Europe
• Deloitte
• Accenture Europe
Get Sample Report@ https://www.reporthive.com/enquiry.php?id=1247388&req_type=smpl&utm_source=AB
Market segment by Type, the product can be split into
• Operations Consultants
• Business Strategy Consultants
• Investment Consultants
• Sales and…
Strategy Consulting Market Analysis 2018: McKinsey, The Boston Consulting Group, …
Orbis Research Present’s “Global Strategy Consulting Market” magnify the decision making potentiality and helps to create an effective counter strategies to gain competitive advantage.
The global Strategy Consulting status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Strategy Consulting development in United States, Europe and China.
In 2017, the global Strategy Consulting market size was million US$ and it is expected to reach million…
Influenza Vaccination Market Global Forecast 2018-25 Estimated with Top Key Play …
UpMarketResearch published an exclusive report on “Influenza Vaccination market” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 115 pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. This report focuses on the Influenza Vaccination market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This…
